tumor and/or ascitic fluid of 16 patients were characterized for MSCs phenotype (CD73, CD90, CD105), CSCs markers (CD24, CD44, CD133), and hematopoietic stem and progenitor marker (CD34) and leukocyte common antigen (CD45). Here, CD24 is linked to neoplasm.